Epsilogen
Early Stage · Website
- Name
- Epsilogen
- According to Albion: Epsilogen
- Stage
- Early Stage
- According to Albion: Early Stage
- Website
- https://epsilogen.com/
- Sectors
- Frontiers Strategy
- According to Albion: Frontiers Strategy
View sources
View sources
View sources
No timeline events.
| Name | Title | Location | |
|---|---|---|---|
| Alek Safarian | Board Member | ||
| Andrew Calam | SVP of Clinical Operations | ||
| Cristina Oliva | Chief Medical Officer | ||
| Elizabeth Hardaker | Chief Translational Science Officer | ||
| Kevin FitzGerald | Chief Scientific Officer | ||
| Leanne Partington | VP of Product Development | ||
| Marianne Bjørdal | Board Member | ||
| Marianne Uteng | Board Member | ||
| Nick Robbins-Cherry | Chief Financial Officer | ||
| Pete Finan | Non-Executive Chairman | ||
| Robert Coleman | Clinical Advisor | ||
| Sonia Gulati | Board Member | ||
| Susana Banerjee | Clinical Advisor | ||
| Thomas Herzog | Clinical Advisor | ||
| Tim Wilson, PhD. | Chief Executive Officer |